Detailed Information
Cited 0 time in 
Cited 0 time in 
Cited 0 time in
Metadata Downloads
BCR-ABL1 TRANSCRIPT LEVEL ON DAY+28 CAN PREDICT EARLY MOLECULAR RESPONSE AT 3 MONTHS AND MAJOR MOLECULAR RESPONSE AT 12 MONTHS IN CHRONIC MYELOID LEUKEMIA PATIENTS WHO TREATED WITH FRONTLINE DASATINIB
Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | 원영웅 | - |
| dc.date.accessioned | 2021-08-03T06:23:09Z | - |
| dc.date.available | 2021-08-03T06:23:09Z | - |
| dc.date.issued | 2016-06-10 | - |
| dc.identifier.uri | https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/36331 | - |
| dc.title | BCR-ABL1 TRANSCRIPT LEVEL ON DAY+28 CAN PREDICT EARLY MOLECULAR RESPONSE AT 3 MONTHS AND MAJOR MOLECULAR RESPONSE AT 12 MONTHS IN CHRONIC MYELOID LEUKEMIA PATIENTS WHO TREATED WITH FRONTLINE DASATINIB | - |
| dc.type | Conference | - |
| dc.citation.conferenceName | 21st Congress of the European Hematology Association | - |
| dc.citation.conferencePlace | Copenhagen, Denmark | - |
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - 서울 의과대학 > 서울 내과학교실 > 2. Conference Papers
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
Related Researcher
- Won, Young Woong
- 서울 의과대학 (DEPARTMENT OF INTERNAL MEDICINE)